DEF 14A

Company

PMV Pharmaceuticals, Inc.

Filed

April 22, 2022

Period of Report

June 2, 2022

Accession Number

0001140361-22-015508

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →